COSCIENS Biopharma Inc. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
COSCIENS Biopharma Inc. (CSCIF) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $107.93 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2026-03-25
- 2025-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $107.93M.
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $111.12M.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $111.77M.
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $102.84M.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2025-12-31 | $107.93M 20-F · filed 2026-03-25 |
| 2024-12-31 | $111.12M 20-F · filed 2026-03-25 |
| 2023-12-31 | $111.77M 20-F/A · filed 2024-07-17 |
| 2022-12-31 | $102.84M 20-F/A · filed 2024-07-17 |
| 2021-12-31 | $106.72M 20-F/A · filed 2024-02-15 |
| 2020-12-31 | $108.67M 20-F · filed 2022-03-29 |
| 2019-12-31 | $101.93M 40-F/A · filed 2021-03-29 |
| 2018-12-31 | $100.63M 20-F · filed 2020-03-31 |
| 2017-12-31 | $104.07M 20-F · filed 2019-04-01 |
| 2016-12-31 | $92.83M 20-F · filed 2018-03-28 |